Biovie BIVI
NASDAQ BIVI
$1.93 +0.07 (+3.76%)
As of: Aug 21, 2026 · 1:48 PM EDT

Biovie (BIVI) Loans - Net (2018)

Biovie (BIVI) posted Loans - Net of -$250000.0 for Q2 2018.

Biovie (BIVI) Loans - Net (2018) Analysis & Trends

Biovie has reported Loans - Net for 1 years, with the latest figure at -$250000.0 in Q2 2018.

  • Quarterly Loans - Net changed N/A year-over-year to -$250000.0 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was -$250000.0 (changed N/A YoY) and the FY2018 annual result came in at -$250000.0, changed N/A from the prior year.
  • Loans - Net was little changed at -$250000.0 in Q2 2018 per BIVI's latest filing.
  • Over five years, Loans - Net peaked at -$250000.0 in Q2 2018 and troughed at -$250000.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Loans - Net (Qtr)
1 Vertex Pharmaceuticals 139.41 Bn 131.56 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.14 Bn 78.15 Bn 3.93 Bn -
3 Argenx Se 65.52 Bn 60.34 Bn 1.37 Bn -
4 Moderna 58.21 Bn 53.07 Bn 52.00 Mn -
5 BeOne Medicines 42.15 Bn 37.05 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn -
7 BioNTech SE 27.95 Bn 9.56 Bn 668.28 Mn -
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
9 Royalty Pharma 27.30 Bn 26.46 Bn - -
10 Biovie 13.91 Mn 13.91 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2018 -250,000.00
Jun 30, 2018 -250,000.00